Cargando…

Researching the Phenomenon of Poor Ovarian Responders and Management Strategies in IVF: A Narrative Review

This narrative review aims to summarize all the latest studies published between 2015-2021 concerning the management protocols adopted for poor ovarian response (POR) cases. Patients defined as “poor responders” show minimal response to controlled ovarian hyperstimulation, although there is no stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Galatis, Dionysios, Kalopita, Konstantina, Grypiotis, Ioannis, Flessas, Ioannis, Kiriakopoulos, Nikolaos, Micha, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Sciences and Arts of Bosnia and Herzegovina 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982854/
https://www.ncbi.nlm.nih.gov/pubmed/36318003
http://dx.doi.org/10.5644/ama2006-124.379
Descripción
Sumario:This narrative review aims to summarize all the latest studies published between 2015-2021 concerning the management protocols adopted for poor ovarian response (POR) cases. Patients defined as “poor responders” show minimal response to controlled ovarian hyperstimulation, although there is no standard definition for POR. Although infertility specialists are endeavoring to improve cycle outcomes in poor responders by adopting multiple management strategies, still the estimated risk of cycle cancellation is about 20%. All the studies performed during this study period were evaluated and their results were recorded. The latest published protocols to improve oocyte retrieval in poor responders include anti-Mϋllerian hormone, clomiphene citrate, co-enzyme Q(10,) corifollitropin, dehydroepiandrosterone, double stimulation, Follicle Stimulation Hormone, Growth Hormone, Gonadotropin-releasing hormone agonists, letrozole, human chorionic gonadotropin, Luteinizing Hormone, progesterone and testosterone. CONCLUSION. Although many strategies have been suggested to manage POR, none has been proven superior to the others. Further large-scale randomized studies are needed to validate experimental techniques leading towards successful individualized treatment regimens.